• Milestone Pharmaceuticals granted 288,000 stock options under its 2021 Inducement Plan to six newly hired employees.
• Options were issued July 1, 2026, with an exercise price of $1.32 per share, matching the stock’s closing price.
• Awards vest over four years: 25% after one year, with the remainder vesting in equal monthly installments over the next 36 months.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Milestone Pharmaceuticals Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202607022130PRIMZONEFULLFEED9756595) on July 03, 2026, and is solely responsible for the information contained therein.